MAM
SCPH

Meeder Asset Management’s scPharmaceuticals SCPH Stock Holding History

Meeder Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-729
Closed -$6K – 2409
2020
Q1 		$6K Sell
729
-361
-33% -$2.62K ﹤0.01% 1726
2019
Q4 		$6K Hold
1,090
– – ﹤0.01% 1735
2019
Q3 		$6K Buy
1,090
+123
+13% +$694 ﹤0.01% 1711
2019
Q2 		$3K Buy
967
+563
+139% +$1.84K ﹤0.01% 1807
2019
Q1 		$1K Buy
404
+129
+47% +$443 ﹤0.01% 1638
2018
Q4 		$1K Buy
+275
New +$1.29K ﹤0.01% 1648

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Meeder Asset Management's SCPH Position: Q2 2020 in Review

Meeder Asset Management sold out of scPharmaceuticals (SCPH) in Q2 2020, closing a stake of 729 shares — an estimated $6K sold.

Meeder Asset Management first reported a position in SCPH in Q4 2018 and held it in 6 quarters. The position peaked at $6K in Q1 2020. 51 funds tracked by Wall St. Rank hold SCPH as of Q2 2020.

  • Meeder Asset Management reported no remaining scPharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 729 scPharmaceuticals shares in Q2 2020, an estimated $6K.
  • Meeder Asset Management first reported a position in scPharmaceuticals in Q4 2018 and held it in 6 quarters.
  • Meeder Asset Management's scPharmaceuticals position peaked at $6K in Q1 2020.
  • 51 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.